MiMedx director receives 50,913-share stock grant
BIERMAN JAMES L reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BIERMAN JAMES L reported acquisition or exercise transactions in this Form 4 filing.
MIMEDX GROUP, INC. director James L. Bierman received an annual restricted stock grant of 50,913 shares of common stock on June 10, 2026 at $3.64 per share. The award to this non-employee director vests upon the earlier of 12 months or the next meeting of shareholders, bringing his direct holdings to 263,684 shares. This is a compensation-related equity award, not an open-market purchase.
Insider Trade Summary
Grant/Award: 50,913 shares
Grant/Award
1 txn
Insider
BIERMAN JAMES L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 50,913 | $3.64 | $185K |
Holdings After Transaction:
Common Stock — 263,684 shares (Direct)
Footnotes (1)
- F1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.
Key Figures
Restricted stock grant size: 50,913 shares
Grant price per share: $3.64 per share
Shares held after grant: 263,684 shares
+2 more
5 metrics
Restricted stock grant size
50,913 shares
Annual restricted stock grant to non-employee director
Grant price per share
$3.64 per share
Reported value for the June 10, 2026 grant
Shares held after grant
263,684 shares
Director’s total direct holdings following the transaction
Vesting condition
Earlier of 12 months or next shareholder meeting
Restricted stock vesting schedule for the award
Transaction code
A (grant, award, or other acquisition)
Form 4 classification of the equity award
Key Terms
restricted stock, Rule 16b-3, non-employee directors, vesting
4 terms
restricted stock financial
"Represents annual restricted stock grant to non-employee directors."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Rule 16b-3 regulatory
"Grant is exempt under Rule 16b-3."
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
non-employee directors financial
"Represents annual restricted stock grant to non-employee directors."
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
vesting financial
"The award vests upon the earlier of 12 months or the next meeting of shareholders."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MiMedx (MDXG) report for James L. Bierman?
MiMedx reported that director James L. Bierman received an annual restricted stock grant of 50,913 common shares. This equity award is classified as a grant or other acquisition, not an open-market purchase, and is part of his compensation as a non-employee director.
At what price was James L. Bierman’s restricted stock grant at MiMedx (MDXG) recorded?
The restricted stock grant to James L. Bierman was recorded at $3.64 per share. This reflects the fair value used for reporting purposes and helps investors understand the size of the director’s equity-based compensation relative to the company’s share price.
Is James L. Bierman’s MiMedx (MDXG) stock grant an open-market purchase or a compensation award?
The transaction is a compensation-related award, not an open-market purchase. It is reported as a grant or other acquisition of 50,913 restricted shares, exempt under Rule 16b-3, reflecting standard equity compensation for a non-employee director of MiMedx.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates